Arrhythmia Risk Prediction in Patients With Preserved Left Ventricular Function. The Final Frontier?**Editorials appearing in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 48, Issue 11, 2006, Pages 2275-2276

  Klingenheben, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CARDIOVASCULAR RISK; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAM; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE VARIABILITY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HOLTER MONITORING; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK REDUCTION; SUDDEN DEATH; T WAVE;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 33845226147     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.08.025     Document Type: Editorial

References (12)

1. Myerburg R.J., Interian A., Mitrani R.N., et al. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 80 Suppl (1997) F10-F19
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
4. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
5. Klingenheben T., Zabel M., D'Agostino R.B., et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
6. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
7. Hohnloser S.H., Ikeda T., Bloomfield D.M., et al. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362 (2003) 125-126
8. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
9. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
10. Ikeda T., Yoshino H., Sugi K., et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial function: results of a collaborative cohort study. J Am Coll Cardiol 48 (2006) 2268-2274
11. Bauer A., Kantelhardt J.W., Barthel P., et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367 (2006) 1674-1681
12. Viskin S. Prediction versus prevention of sudden cardiac death. Lancet 367 (2006) 1639-1641